Sri Lanka vs United Arab Emirates: Proportion of bloodstream infection due to methicillin-resistant
Sri Lanka
48.6%
in 2023
United Arab Emirates
41.4%
in 2023
Sri Lanka rank
14th
United Arab Emirates rank
17th
Proportion of bloodstream infection due to methicillin-resistant over time
- Sri Lanka
- United Arab Emirates
How they compare
Sri Lanka currently reports 48.6% against 41.4% in United Arab Emirates, a difference of 7.2%.
That makes Sri Lanka's figure about 1.2 times United Arab Emirates's.
Across all 5 years both countries report, Sri Lanka has been ahead every year.
Sri Lanka ranks 14th and United Arab Emirates ranks 17th of 55 countries.
Sri Lanka has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sri Lanka | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.0% | 36.2% | 19.8% | Sri Lanka |
| 2020s | 50.1% | 39.9% | 10.2% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Sri Lanka or United Arab Emirates?
- Sri Lanka, at 48.6% against 41.4% in United Arab Emirates as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Sri Lanka and United Arab Emirates?
- 7.2%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and United Arab Emirates?
- 5 years are reported by both, from 2019 to 2023.
- How do Sri Lanka and United Arab Emirates rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Sri Lanka ranks 14th and United Arab Emirates ranks 17th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.